SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-076364
Filing Date
2023-09-13
Accepted
2023-09-13 16:03:03
Documents
51
Period of Report
2023-09-13

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea185167-6k_nlspharma.htm 6-K 16180
2 COMPANY PRESENTATION ea185167ex99-1_nlspharma.htm EX-99.1 65319
3 GRAPHIC ex99-1_001.jpg GRAPHIC 803857
4 GRAPHIC ex99-1_002.jpg GRAPHIC 1323783
5 GRAPHIC ex99-1_003.jpg GRAPHIC 216266
6 GRAPHIC ex99-1_004.jpg GRAPHIC 864228
7 GRAPHIC ex99-1_005.jpg GRAPHIC 393019
8 GRAPHIC ex99-1_006.jpg GRAPHIC 661230
9 GRAPHIC ex99-1_007.jpg GRAPHIC 717621
10 GRAPHIC ex99-1_008.jpg GRAPHIC 759159
11 GRAPHIC ex99-1_009.jpg GRAPHIC 220430
12 GRAPHIC ex99-1_010.jpg GRAPHIC 679702
13 GRAPHIC ex99-1_011.jpg GRAPHIC 476125
14 GRAPHIC ex99-1_012.jpg GRAPHIC 837915
15 GRAPHIC ex99-1_013.jpg GRAPHIC 576801
16 GRAPHIC ex99-1_014.jpg GRAPHIC 617557
17 GRAPHIC ex99-1_015.jpg GRAPHIC 216801
18 GRAPHIC ex99-1_016.jpg GRAPHIC 484863
19 GRAPHIC ex99-1_017.jpg GRAPHIC 956815
20 GRAPHIC ex99-1_018.jpg GRAPHIC 249405
21 GRAPHIC ex99-1_019.jpg GRAPHIC 469943
22 GRAPHIC ex99-1_020.jpg GRAPHIC 688488
23 GRAPHIC ex99-1_021.jpg GRAPHIC 264808
24 GRAPHIC ex99-1_022.jpg GRAPHIC 595397
25 GRAPHIC ex99-1_023.jpg GRAPHIC 224480
26 GRAPHIC ex99-1_024.jpg GRAPHIC 238834
27 GRAPHIC ex99-1_025.jpg GRAPHIC 659142
28 GRAPHIC ex99-1_026.jpg GRAPHIC 246202
29 GRAPHIC ex99-1_027.jpg GRAPHIC 474616
30 GRAPHIC ex99-1_028.jpg GRAPHIC 429008
31 GRAPHIC ex99-1_029.jpg GRAPHIC 235367
32 GRAPHIC ex99-1_030.jpg GRAPHIC 645188
33 GRAPHIC ex99-1_031.jpg GRAPHIC 466225
34 GRAPHIC ex99-1_032.jpg GRAPHIC 236586
35 GRAPHIC ex99-1_033.jpg GRAPHIC 565952
36 GRAPHIC ex99-1_034.jpg GRAPHIC 717662
37 GRAPHIC ex99-1_035.jpg GRAPHIC 679440
38 GRAPHIC ex99-1_036.jpg GRAPHIC 251707
39 GRAPHIC ex99-1_037.jpg GRAPHIC 652418
40 GRAPHIC ex99-1_038.jpg GRAPHIC 500625
41 GRAPHIC ex99-1_039.jpg GRAPHIC 580753
42 GRAPHIC ex99-1_040.jpg GRAPHIC 689893
43 GRAPHIC ex99-1_041.jpg GRAPHIC 790929
44 GRAPHIC ex99-1_042.jpg GRAPHIC 760379
45 GRAPHIC ex99-1_043.jpg GRAPHIC 253014
46 GRAPHIC ex99-1_044.jpg GRAPHIC 709010
47 GRAPHIC ex99-1_045.jpg GRAPHIC 167454
48 GRAPHIC ex99-1_046.jpg GRAPHIC 206644
49 GRAPHIC ex99-1_047.jpg GRAPHIC 605267
50 GRAPHIC ex99-1_048.jpg GRAPHIC 434756
51 GRAPHIC ex99-1_049.jpg GRAPHIC 809906
  Complete submission text file 0001213900-23-076364.txt   36304417
Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370
Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39957 | Film No.: 231252682
SIC: 2834 Pharmaceutical Preparations